Principal Financial Group Inc. Boosts Position in Cabot Corporation $CBT

Principal Financial Group Inc. raised its holdings in shares of Cabot Corporation (NYSE:CBTFree Report) by 6.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 177,368 shares of the specialty chemicals company’s stock after acquiring an additional 10,765 shares during the period. Principal Financial Group Inc. owned approximately 0.34% of Cabot worth $13,358,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in CBT. Norges Bank purchased a new position in shares of Cabot during the fourth quarter worth $49,662,000. AQR Capital Management LLC boosted its holdings in Cabot by 123.0% in the second quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock valued at $65,096,000 after purchasing an additional 478,702 shares during the last quarter. UBS Group AG grew its position in Cabot by 186.7% during the 3rd quarter. UBS Group AG now owns 593,510 shares of the specialty chemicals company’s stock worth $45,136,000 after purchasing an additional 386,514 shares during the period. Pacer Advisors Inc. grew its position in Cabot by 3,165.7% during the 4th quarter. Pacer Advisors Inc. now owns 229,252 shares of the specialty chemicals company’s stock worth $15,195,000 after purchasing an additional 222,232 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund purchased a new position in shares of Cabot during the 4th quarter valued at about $8,785,000. 93.18% of the stock is owned by hedge funds and other institutional investors.

Cabot Price Performance

NYSE:CBT opened at $90.15 on Friday. The company has a quick ratio of 0.96, a current ratio of 1.45 and a debt-to-equity ratio of 0.51. Cabot Corporation has a 52 week low of $58.33 and a 52 week high of $94.53. The stock’s 50-day moving average price is $86.94 and its 200-day moving average price is $78.73. The stock has a market capitalization of $4.65 billion, a PE ratio of 17.04, a price-to-earnings-growth ratio of 11.60 and a beta of 0.83.

Cabot (NYSE:CBTGet Free Report) last released its quarterly earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share for the quarter, topping analysts’ consensus estimates of $1.47 by $0.14. Cabot had a return on equity of 21.33% and a net margin of 7.97%.The company had revenue of $904.00 million during the quarter, compared to analysts’ expectations of $900.30 million. During the same quarter in the prior year, the firm posted $1.90 EPS. Cabot’s quarterly revenue was down 3.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. As a group, equities analysts expect that Cabot Corporation will post 6.35 EPS for the current fiscal year.

Cabot Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 28th will be given a dividend of $0.4725 per share. The ex-dividend date is Friday, August 28th. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.1%. Cabot’s dividend payout ratio (DPR) is 35.73%.

Analyst Ratings Changes

CBT has been the subject of several analyst reports. UBS Group boosted their price objective on Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a report on Friday, May 8th. Mizuho lifted their price target on Cabot from $80.00 to $90.00 and gave the company a “neutral” rating in a research report on Thursday, June 25th. Truist Financial assumed coverage on Cabot in a report on Monday, June 8th. They issued a “buy” rating and a $98.00 price target for the company. Wall Street Zen upgraded Cabot from a “hold” rating to a “buy” rating in a research report on Sunday, June 14th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Cabot from $68.00 to $70.00 and gave the stock an “underweight” rating in a research note on Wednesday, May 13th. Two investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $85.80.

View Our Latest Stock Report on CBT

Cabot Company Profile

(Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Further Reading

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBTFree Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.